Kazia Therapeutics Limited (KZIA) DCF Valuation

Valoración de DCF de Kazia Therapeutics Limited (KZIA)

AU | Healthcare | Biotechnology | NASDAQ
Kazia Therapeutics Limited (KZIA) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Kazia Therapeutics Limited (KZIA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF (KZIA)! Explore datos financieros reales de Kazia Therapeutics, ajuste las predicciones y gastos de crecimiento, y visualice instantáneamente cómo estos cambios afectan el valor intrínseco de (KZIA).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 9.4 .0 .0 1.4 2.2 3.2 4.8 7.3 10.9
Revenue Growth, % 0 1430881.24 -100 2120 415755.86 50 50 50 50 50
EBITDA -6.9 -3.2 -14.6 -13.9 -16.7 -1.9 -2.8 -4.2 -6.3 -9.5
EBITDA, % -1047076.53 -33.68 -94059236 -4013885.95 -1159.71 -86.74 -86.74 -86.74 -86.74 -86.74
Depreciation .7 .8 1.2 1.2 1.2 1.7 2.5 3.8 5.7 8.5
Depreciation, % 102200.19 8.33 7477680 336839.64 80.98 77.86 77.86 77.86 77.86 77.86
EBIT -7.6 -4.0 -15.8 -15.0 -17.8 -1.9 -2.9 -4.3 -6.4 -9.6
EBIT, % -1149276.72 -42.01 -101536916 -4350725.59 -1240.68 -88.4 -88.4 -88.4 -88.4 -88.4
Total Cash 5.5 17.2 4.6 3.3 1.0 2.0 3.0 4.6 6.9 10.3
Total Cash, percent .8 .0 29.4 .9 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .1
Account Receivables, % 41.38 0 204000 109.91 5.76
Inventories .0 -.1 .0 -2.4 .0 -.4 -.6 -1.0 -1.5 -2.2
Inventories, % 0.09425071 -0.55325 0 -683666.85 0 -20.09 -20.09 -20.09 -20.09 -20.09
Accounts Payable 1.1 1.2 .9 .5 2.8 1.8 2.7 4.0 6.0 9.0
Accounts Payable, % 159660.7 12.47 6096000 154414.41 197.05 82.49 82.49 82.49 82.49 82.49
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 0 0 0 0 0 0 0 0 0
Tax Rate, % 1 1 1 1 1 1 1 1 1 1
EBITAT -7.4 -3.8 -15.6 -14.8 -17.6 -1.9 -2.8 -4.2 -6.3 -9.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.7 -2.8 -14.7 -11.7 -16.6 -1.8 .3 .4 .7 1.0
WACC, % 4.35 4.21 4.38 4.39 4.41 4.35 4.35 4.35 4.35 4.35
PV UFCF
SUM PV UFCF .3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 1
Terminal Value 44
Present Terminal Value 35
Enterprise Value 36
Net Debt -1
Equity Value 36
Diluted Shares Outstanding, MM 18
Equity Value Per Share 1.97

What You Will Receive

  • Adjustable Forecast Parameters: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Comprehensive Market Data: Kazia Therapeutics Limited’s financial data pre-loaded to facilitate your analysis.
  • Instant DCF Calculations: The template automatically computes Net Present Value (NPV) and intrinsic value.
  • Tailored and Professional Design: A refined Excel model that aligns with your valuation requirements.
  • Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life KZIA Financials: Pre-filled historical and projected data for Kazia Therapeutics Limited (KZIA).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Kazia’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Kazia’s valuation instantly after making adjustments.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Kazia Therapeutics Limited's (KZIA) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated outcomes, including Kazia's intrinsic value.
  • Step 5: Use the results to make informed investment choices or create detailed reports.

Why Choose This Calculator for Kazia Therapeutics Limited (KZIA)?

  • Designed for Experts: A sophisticated tool tailored for analysts, investors, and healthcare consultants.
  • Accurate Data: Kazia’s historical and projected financials preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth user experience.

Who Should Use Kazia Therapeutics Limited (KZIA)?

  • Healthcare Students: Explore drug development processes and apply theoretical knowledge to real-world scenarios.
  • Researchers: Utilize professional models to enhance studies in oncology and pharmaceutical innovation.
  • Investors: Evaluate your investment strategies and analyze potential outcomes for Kazia Therapeutics Limited (KZIA).
  • Pharmaceutical Analysts: Optimize your analysis with a customizable financial model tailored for biotech companies.
  • Entrepreneurs: Understand how biotech firms like Kazia Therapeutics Limited (KZIA) are assessed in the market.

What the Template Contains

  • Historical Data: Includes Kazia Therapeutics Limited’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Kazia Therapeutics Limited’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Kazia Therapeutics Limited’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.